{"gene":"TFAP4","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":1988,"finding":"AP-4 (TFAP4) was isolated as an enhancer-binding factor that recognizes a motif in the SV40 A-domain and activates SV40 late transcription in vitro; this stimulation is augmented by AP-1 binding to adjacent sequences, demonstrating coordinate action of the two factors for transcriptional enhancement.","method":"In vitro transcription assay with purified AP-4 protein","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified factor, foundational discovery paper","pmids":["2833704"],"is_preprint":false},{"year":1990,"finding":"Human AP-4 (TFAP4) is a helix-loop-helix (HLH) protein that binds the symmetrical DNA sequence CAGCTG; it contains an HLH motif plus two additional leucine repeat elements (LR1 and LR2) that promote homodimerization and restrict heterodimer formation with other HLH proteins such as E12. The LR1/LR2 domains are required for solution-phase dimerization, while the HLH-basic region is sufficient for DNA binding.","method":"Molecular cloning, deletion/point mutagenesis, DNA-binding and dimerization assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with multiple biochemical assays, original cloning paper","pmids":["2123466"],"is_preprint":false},{"year":2006,"finding":"TFAP4 represses HIV-1 LTR transcription by recruiting histone deacetylase 1 (HDAC1) to the LTR promoter and by masking TATA-binding protein (TBP) binding to the TATA box; TFAP4 and HDAC1 are present on the LTR in latently infected cells and dissociate upon TNF-α-induced reactivation.","method":"Co-immunoprecipitation, in vitro binding assay, chromatin immunoprecipitation (ChIP), siRNA knockdown, luciferase reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including ChIP, co-IP, in vitro binding, and functional knockdown in a single study","pmids":["16540471"],"is_preprint":false},{"year":2009,"finding":"TFAP4 binds an E-box in the HDM2-P2 promoter via its C-terminal Gln/Pro-rich domain and represses HDM2 transcription in a p53-independent manner; AP-4 forms a complex containing HDAC1, CTCF, SP1, histone methyltransferases, and SWI/SNF components at the HDM2-P2 promoter.","method":"Luciferase reporter assay, AP-4 truncation mutants, DNA-affinity purification followed by quantitative proteomics (cICAT and iTRAQ), co-immunoprecipitation","journal":"Molecular & cellular proteomics","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro binding, mutagenesis, and quantitative MS-based interactomics with orthogonal validation","pmids":["19505873"],"is_preprint":false},{"year":2014,"finding":"During G2 phase of the cell cycle, TFAP4 is targeted for proteasome-dependent degradation by the SCF-βTrCP ubiquitin ligase, requiring phosphorylation of TFAP4 on a conserved degron; expression of a stable TFAP4 mutant unable to interact with βTrCP causes chromosome missegregation, multipolar spindles, and DNA damage response activation.","method":"Biochemical degradation assays, site-directed mutagenesis of degron, cell cycle analysis, immunofluorescence for mitotic defects, mass spectrometry","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — phosphorylation-dependent ubiquitin ligase interaction with mutagenesis and clear cellular phenotype","pmids":["24500709"],"is_preprint":false},{"year":2018,"finding":"TFAP4 activates Wnt/β-catenin signaling in hepatocellular carcinoma by directly binding to the promoters of DVL1 and LEF1, as demonstrated by luciferase reporter and ChIP-qPCR assays.","method":"Luciferase reporter assay, ChIP-qPCR, overexpression/knockdown functional assays","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding demonstrated by ChIP and luciferase reporter in a single lab study","pmids":["30026867"],"is_preprint":false},{"year":2001,"finding":"TFAP4 acts as a transcriptional ligand for immunoglobulin-κ promoter E-box elements (5′-CAGCTG-3′) and does not act as a transactivator at these sites, distinguishing it from E47.","method":"Electrophoretic mobility shift assay (EMSA) with nuclear extracts from human and murine B-cell lines","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 — EMSA with specific nuclear extracts, single lab","pmids":["11171123"],"is_preprint":false},{"year":1994,"finding":"AP-4 participates in BLV Tax trans-activation by binding a CAGCTG AP-4 site in the 21-bp repeats of the BLV LTR; antisense AP-4 RNA strongly reduces Tax activation, indicating AP-4 is required for this viral trans-activation.","method":"Gel retardation assay, in vivo reporter assay, antisense RNA knockdown","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional antisense knockdown combined with binding assay, single lab","pmids":["7800474"],"is_preprint":false},{"year":1998,"finding":"AP-4 binds E-box (CACCTG) motifs in a distal regulatory region of the IGFBP-2 gene and activates IGFBP-2 promoter activity 16-fold when co-transfected with an AP-4 expression vector; stimulation is abolished by mutation of both bHLH motifs.","method":"EMSA, Southwestern blot, co-transfection luciferase reporter assay with AP-4 expression vector","journal":"Endocrine","confidence":"Medium","confidence_rationale":"Tier 2 — direct DNA binding and functional reporter assay with mutagenesis, single lab","pmids":["9741833"],"is_preprint":false},{"year":2011,"finding":"In IGF-1-stimulated breast cancer cells, JNK activation induces SHP1 expression through binding of TFAP4 and RFX-1 transcription factors to the epithelial tissue-specific SHP1 promoter.","method":"Promoter reporter assay, transcription factor binding assay, JNK inhibition experiments","journal":"Molecular cancer research","confidence":"Low","confidence_rationale":"Tier 3 — single lab, limited mechanistic detail on TFAP4-specific binding at promoter","pmids":["21719561"],"is_preprint":false},{"year":2021,"finding":"c-MYC suppresses the stemness of developing B cells and counteracts oncogenesis by inducing TFAP4, which restricts self-renewal of proliferating B cells; CRISPR deletion of TFAP4 in Eµ-MYC hematopoietic stem and progenitor cells accelerates c-MYC-driven lymphoma development and reduces expression of B cell differentiation regulators Spi1, SpiB, and Pax5 that are direct target genes of TFAP4.","method":"CRISPR knockout in primary hematopoietic cells with in vivo transplantation, transcriptional profiling, genetic epistasis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — in vivo epistasis with CRISPR, transcriptome analysis, and clear functional phenotype","pmids":["34283887"],"is_preprint":false},{"year":2015,"finding":"In Drosophila, Cropped (the AP-4 ortholog) is required for tracheal terminal cell branching and is controlled by dMyc; ectopic dMyc increases Cropped protein levels and cellular branching, placing AP-4 downstream of Myc in a branching morphogenesis pathway.","method":"Genetic overexpression and loss-of-function in Drosophila tracheal cells, cell counting, protein level analysis","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic epistasis in Drosophila ortholog, single lab","pmids":["25888431"],"is_preprint":false},{"year":2019,"finding":"TFAP4 directly binds to the promoter of OX40 (acting as its transcription factor) and promotes OX40 expression, thereby accelerating double-negative T cell (DNT) differentiation; myeloid-specific TFAP4 knockout reduced DNTs in liver tissue and delayed liver fibrosis progression.","method":"Luciferase reporter assay, ChIP, overexpression and myeloid-specific knockout mouse model","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding by ChIP/luciferase combined with in vivo KO phenotype, single lab","pmids":["37060810"],"is_preprint":false},{"year":2022,"finding":"TFAP4 transcriptionally activates IGF2BP1 by binding its promoter; IGF2BP1 then stabilizes TK1 mRNA via m6A modification to promote NSCLC cell proliferation, migration, and invasion.","method":"ChIP assay, luciferase reporter assay, m6A modification detection, knockdown/overexpression, in vivo xenograft","journal":"Molecular cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding by ChIP/luciferase with downstream mechanistic follow-up, single lab","pmids":["36074102"],"is_preprint":false},{"year":2024,"finding":"TFAP4 transcriptionally activates the USP15 promoter (confirmed by ChIP and pull-down assay); USP15 in turn deubiquitinates and stabilizes SHC1 protein, promoting renal cell carcinoma malignancy.","method":"ChIP assay, oligonucleotide pull-down assay, co-immunoprecipitation, ubiquitination assay, in vivo xenograft","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal assays establishing TFAP4→USP15 transcriptional axis, single lab","pmids":["38847328"],"is_preprint":false},{"year":2024,"finding":"USP15 deubiquitinates TFAP4 and enhances its protein stability; stabilized TFAP4 transcriptionally activates PCGF1 to promote colorectal cancer metastasis and stemness.","method":"Co-immunoprecipitation, dual luciferase reporter assay, oligonucleotide pull-down, ChIP assay, in vivo liver metastasis model","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal biochemical methods establishing deubiquitination and transcriptional activation, single lab","pmids":["38801926"],"is_preprint":false},{"year":2019,"finding":"TFAP4 binds the rs1800734 region of the MLH1 promoter (confirmed by allele-specific binding assay), but binding is much weaker to the cancer risk allele than the protective allele; TFAP4 binding is absent when promoter methylation is present, suggesting TFAP4 shields the protective allele from BRAF-induced methylation.","method":"Allele-specific TFAP4 binding assay, methylation analysis, re-expression after methylation inhibitor treatment","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding assay with allele-specific discrimination and functional follow-up, single lab","pmids":["31530880"],"is_preprint":false},{"year":2025,"finding":"TFAP4 directly activates expression of mechanosensors Itga11 and Piezo2 (confirmed by ChIP/luciferase), promoting cardiac fibroblast activation, ECM deposition, and myofibroblast differentiation; silencing Itga11 and Piezo2 reverses TFAP4's pro-fibrotic effects.","method":"ChIP assay, luciferase reporter assay, overexpression/knockdown, in vivo mouse post-MI model","journal":"Cell insight","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding by ChIP/luciferase with in vivo validation, single lab","pmids":["40612272"],"is_preprint":false},{"year":2025,"finding":"TFAP4 transcriptionally activates the DLGAP5 promoter (confirmed by ChIP and luciferase assay); the TFAP4/DLGAP5 axis activates JAK2/STAT3 signaling in prostate cancer cells to promote tumor progression and macrophage M2 polarization.","method":"ChIP assay, luciferase reporter assay, knockdown/overexpression, co-culture macrophage polarization assay, in vivo xenograft","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding by ChIP/luciferase with pathway inhibitor validation, single lab","pmids":["40962169"],"is_preprint":false},{"year":2025,"finding":"TFAP4 binds the STING promoter and transcriptionally activates STING expression (shown by luciferase reporter gene experiment), thereby promoting STING signaling pathway activation and progression of liver fibrosis.","method":"Luciferase reporter assay, AAV8-TFAP4 overexpression in mice, STING-KO mouse epistasis","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — luciferase reporter with in vivo epistasis (STING-KO), single lab","pmids":["39827671"],"is_preprint":false},{"year":2018,"finding":"TFAP4 directly binds E-box motifs in the TRERNA1 promoter and transcriptionally regulates TRERNA1 long non-coding RNA expression in gastric cancer cells (confirmed by dual luciferase reporter and ChIP assay); TRERNA1 promotes gastric cancer cell migration and invasion.","method":"Dual luciferase reporter assay, ChIP, knockdown/overexpression","journal":"Oncology reports","confidence":"Medium","confidence_rationale":"Tier 2 — direct promoter binding by ChIP and luciferase reporter, single lab","pmids":["29845218"],"is_preprint":false},{"year":2025,"finding":"TFAP4 transcriptionally activates FOXK1 expression in prostate cancer; FOXK1 overexpression reverses the effects of TFAP4 knockdown on cell viability, migration, and invasion.","method":"RT-qPCR, Western blot, rescue overexpression experiment, CCK-8, Transwell assays","journal":"Experimental and therapeutic medicine","confidence":"Low","confidence_rationale":"Tier 3 — genetic rescue experiment without direct promoter binding assay","pmids":["34630654"],"is_preprint":false},{"year":2025,"finding":"In T-ALL, TFAP4 binds an enhancer element to fine-tune Galectin-9 expression (identified by genome-wide CRISPR screen and transcription factor binding assay), while IRF1 binds the promoter as the primary driver.","method":"Genome-wide CRISPR screen, transcription factor binding assay, enhancer mapping, chromatin accessibility analysis","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 — genome-wide unbiased CRISPR screen validated by direct binding assay, single lab","pmids":["40106574"],"is_preprint":false},{"year":2024,"finding":"TFAP4 transcriptionally activates BPTF expression and promotes EMT through activating the PI3K/AKT signaling pathway in neuroblastoma, with BPTF acting as the downstream effector.","method":"Western blot, knockdown/overexpression, functional assays; upstream regulatory relationship inferred from protein co-expression and inhibitor studies","journal":"Biological procedures online","confidence":"Low","confidence_rationale":"Tier 3 — no direct promoter binding assay for TFAP4→BPTF; mechanism largely inferred","pmids":["37170211"],"is_preprint":false},{"year":2024,"finding":"TFAP4 is required for differentiation and fusion of bovine satellite cells into myofibers; active enhancers in differentiating satellite cells are enriched for TFAP4 binding sites, and TFAP4 knockdown or overexpression experimentally alters differentiation.","method":"ChIP-seq for histone modifications, TFAP4 knockdown and overexpression in bovine satellite cells","journal":"BMC genomics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-seq-based chromatin profiling combined with functional KD/OE with defined differentiation phenotype","pmids":["38475725"],"is_preprint":false}],"current_model":"TFAP4 is a basic helix-loop-helix transcription factor that homodimerizes via leucine repeat elements and binds CAGCTG E-box motifs to activate or repress target gene transcription; it is degraded during G2 phase by SCF-βTrCP-mediated, phosphorylation-dependent ubiquitination to ensure mitotic fidelity, recruits HDAC1 to repress HIV-1 LTR transcription by masking TBP, and directly activates or represses a broad network of target gene promoters (including DVL1, LEF1, OX40, STING, Itga11, Piezo2, IGF2BP1, TRERNA1, and DLGAP5) involved in Wnt/β-catenin signaling, autophagy, immune regulation, and cancer progression."},"narrative":{"teleology":[{"year":1988,"claim":"The identity and basic function of AP-4 were unknown; purification and in vitro transcription showed it is an enhancer-binding factor that activates SV40 late transcription, establishing it as a sequence-specific transcriptional activator.","evidence":"In vitro transcription assay with purified AP-4 protein on SV40 templates","pmids":["2833704"],"confidence":"High","gaps":["No DNA-binding motif defined","No structural information on protein domains","In vivo relevance not tested"]},{"year":1990,"claim":"The structural basis for TFAP4 DNA binding and dimerization was unknown; cloning and mutagenesis revealed a bHLH protein with two additional leucine repeat elements that enforce homodimerization and restrict heterodimer formation, binding the symmetric CAGCTG E-box.","evidence":"Molecular cloning, deletion/point mutagenesis, and DNA-binding/dimerization assays","pmids":["2123466"],"confidence":"High","gaps":["No crystal structure of HLH+LR domains","Functional consequences of homodimerization specificity unknown","No in vivo target genes identified"]},{"year":1994,"claim":"Whether TFAP4 participates in viral gene regulation beyond SV40 was unclear; antisense knockdown showed AP-4 is required for BLV Tax transactivation through binding CAGCTG sites in the BLV LTR, broadening its role to retroviral transcription.","evidence":"Gel retardation assay and antisense RNA knockdown with in vivo reporter assay in BLV system","pmids":["7800474"],"confidence":"Medium","gaps":["Mechanism of Tax–AP-4 cooperation not defined at protein level","No chromatin-level evidence"]},{"year":2006,"claim":"The mechanism by which TFAP4 represses transcription was unknown; HDAC1 co-immunoprecipitation and ChIP on the HIV-1 LTR showed TFAP4 recruits HDAC1 and masks TBP binding to enforce latency, establishing a dual repressive mechanism.","evidence":"Co-IP, in vitro binding, ChIP, siRNA knockdown, and luciferase reporter in latently HIV-1-infected cells","pmids":["16540471"],"confidence":"High","gaps":["Whether HDAC1 recruitment is a general TFAP4 repression mechanism or LTR-specific","No structural model of TFAP4–HDAC1 interface"]},{"year":2009,"claim":"The composition of TFAP4 repressive complexes was poorly defined; quantitative proteomics at the HDM2-P2 promoter revealed TFAP4 forms a multisubunit complex with HDAC1, CTCF, SP1, histone methyltransferases, and SWI/SNF components, indicating it operates within a broader chromatin-remodeling assemblage.","evidence":"DNA-affinity purification with cICAT/iTRAQ quantitative mass spectrometry, co-IP, and truncation mutagenesis","pmids":["19505873"],"confidence":"High","gaps":["Stoichiometry and stability of the complex not determined","Whether this complex composition is promoter-specific"]},{"year":2014,"claim":"How TFAP4 protein levels are controlled during the cell cycle was unknown; biochemical and mutagenesis experiments showed SCF-βTrCP ubiquitinates TFAP4 in a phosphorylation-dependent manner during G2, and a non-degradable mutant causes mitotic defects, linking TFAP4 turnover to mitotic fidelity.","evidence":"Degradation assays, degron mutagenesis, cell cycle synchronization, mass spectrometry for phosphorylation, immunofluorescence for mitotic phenotypes","pmids":["24500709"],"confidence":"High","gaps":["Kinase responsible for degron phosphorylation not identified","Whether TFAP4 re-accumulation in G1 is transcriptionally or translationally regulated"]},{"year":2018,"claim":"Whether TFAP4 has pathway-level transcriptional outputs in cancer was unclear; ChIP-qPCR and reporter assays demonstrated direct binding and activation of DVL1 and LEF1 promoters, establishing TFAP4 as an activator of Wnt/β-catenin signaling in hepatocellular carcinoma.","evidence":"Luciferase reporter, ChIP-qPCR, overexpression/knockdown in HCC cell lines","pmids":["30026867"],"confidence":"Medium","gaps":["Genome-wide set of Wnt pathway targets not defined","Contribution relative to other E-box factors unknown"]},{"year":2021,"claim":"The in vivo role of TFAP4 downstream of MYC in normal and malignant hematopoiesis was unresolved; CRISPR deletion in Eμ-MYC HSPCs with transplantation showed TFAP4 restricts B-cell self-renewal and activates differentiation regulators (Spi1, SpiB, Pax5), and its loss accelerates lymphomagenesis.","evidence":"CRISPR KO in primary murine hematopoietic cells, in vivo transplantation, transcriptome profiling","pmids":["34283887"],"confidence":"High","gaps":["Direct ChIP-seq for TFAP4 at differentiation gene loci not reported","Whether TFAP4 tumor-suppressive function extends beyond MYC-driven B-cell lymphoma"]},{"year":2022,"claim":"The expanding target gene network of TFAP4 in cancer raised questions about downstream effector mechanisms; ChIP and reporter assays showed TFAP4 directly activates IGF2BP1, which stabilizes TK1 mRNA via m6A, connecting TFAP4 to epitranscriptomic regulation of proliferation.","evidence":"ChIP, luciferase reporter, m6A detection, knockdown/overexpression, in vivo xenograft in NSCLC","pmids":["36074102"],"confidence":"Medium","gaps":["Genome-wide TFAP4 ChIP-seq in NSCLC not performed","Whether m6A-dependent mRNA stabilization is a general downstream axis"]},{"year":2024,"claim":"TFAP4 protein stability regulation beyond SCF-βTrCP was unknown; co-IP and ubiquitination assays showed USP15 deubiquitinates TFAP4 to enhance its stability, and stabilized TFAP4 activates PCGF1 to promote colorectal cancer metastasis, revealing a reciprocal TFAP4–USP15 regulatory circuit.","evidence":"Co-IP, dual luciferase, ChIP, oligonucleotide pull-down, in vivo liver metastasis model (CRC); complementary study showing TFAP4 activates USP15 transcription in RCC","pmids":["38801926","38847328"],"confidence":"Medium","gaps":["Whether the USP15–TFAP4 reciprocal axis operates in normal tissues","Relative contribution of SCF-βTrCP vs USP15 to steady-state TFAP4 levels"]},{"year":2025,"claim":"The breadth of TFAP4 transcriptional targets in fibrosis and immune signaling was emerging; multiple studies confirmed direct promoter activation of STING, Itga11, Piezo2, and DLGAP5, linking TFAP4 to innate immune signaling, mechanotransduction in cardiac fibrosis, and JAK2/STAT3 activation.","evidence":"ChIP, luciferase reporter, in vivo AAV8 overexpression, STING-KO epistasis, post-MI mouse models, xenograft with macrophage co-culture","pmids":["39827671","40612272","40962169"],"confidence":"Medium","gaps":["No genome-wide ChIP-seq defining complete TFAP4 regulon in any fibrosis model","Selectivity mechanism for activator vs repressor function at different promoters unknown"]},{"year":null,"claim":"Key unresolved questions include the identity of the kinase(s) that phosphorylate the TFAP4 degron for SCF-βTrCP recognition, the structural basis for how TFAP4 switches between activator and repressor modes, the comprehensive genome-wide direct target repertoire (no TFAP4 ChIP-seq in human cells has been reported), and the physiological roles of TFAP4 in normal development beyond hematopoiesis and Drosophila tracheal branching.","evidence":"","pmids":[],"confidence":"Low","gaps":["Degron kinase identity unknown","No crystal or cryo-EM structure of TFAP4 homodimer on DNA","No comprehensive human TFAP4 ChIP-seq dataset","Conditional knockout phenotypes in mammalian tissues beyond hematopoietic and myeloid lineages not reported"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,3,5,6,7,8,16,20,22,24]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,3,5,10,12,13,14,17,18,19,20]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,2,3,4]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[4]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[2,3]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,18,19]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[12,22]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[4,15]}],"complexes":[],"partners":["HDAC1","BTRC","USP15","CTCF","SP1"],"other_free_text":[]},"mechanistic_narrative":"TFAP4 is a basic helix-loop-helix (bHLH) transcription factor that homodimerizes through leucine repeat elements and binds CAGCTG E-box motifs to activate or repress a broad repertoire of target gene promoters and enhancers, thereby regulating cell proliferation, differentiation, immune signaling, and fibrosis [PMID:2123466, PMID:2833704]. TFAP4 recruits HDAC1 and additional chromatin-modifying complexes to repress transcription at specific loci, including the HIV-1 LTR and the HDM2-P2 promoter, while functioning as a transcriptional activator at numerous other targets including DVL1, LEF1, STING, IGF2BP1, DLGAP5, OX40, Itga11, and Piezo2 [PMID:16540471, PMID:19505873, PMID:30026867, PMID:39827671, PMID:36074102]. During G2 phase, TFAP4 is degraded by SCF-βTrCP-mediated, phosphorylation-dependent ubiquitination; failure to degrade TFAP4 causes chromosome missegregation and multipolar spindles, establishing a cell-cycle-coupled mechanism that ensures mitotic fidelity [PMID:24500709]. As a downstream effector of c-MYC, TFAP4 restricts self-renewal in proliferating B cells by activating differentiation regulators such as Spi1, SpiB, and Pax5, and its loss accelerates MYC-driven lymphomagenesis [PMID:34283887]."},"prefetch_data":{"uniprot":{"accession":"Q01664","full_name":"Transcription factor AP-4","aliases":["Activating enhancer-binding protein 4","Class C basic helix-loop-helix protein 41","bHLHc41"],"length_aa":338,"mass_kda":38.7,"function":"Transcription factor that activates both viral and cellular genes by binding to the symmetrical DNA sequence 5'-CAGCTG-3'","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q01664/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TFAP4","classification":"Not Classified","n_dependent_lines":361,"n_total_lines":1208,"dependency_fraction":0.298841059602649},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TFAP4","total_profiled":1310},"omim":[{"mim_id":"609682","title":"DNA CROSS-LINK REPAIR PROTEIN 1A; DCLRE1A","url":"https://www.omim.org/entry/609682"},{"mim_id":"607990","title":"UBIQUITIN-LIKE PROTEIN CONTAINING PHD AND RING FINGER DOMAINS 1; UHRF1","url":"https://www.omim.org/entry/607990"},{"mim_id":"604325","title":"PROTEIN PHOSPHATASE 2, REGULATORY SUBUNIT B, BETA; PPP2R2B","url":"https://www.omim.org/entry/604325"},{"mim_id":"600743","title":"TRANSCRIPTION FACTOR AP4; TFAP4","url":"https://www.omim.org/entry/600743"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TFAP4"},"hgnc":{"alias_symbol":["AP-4","bHLHc41"],"prev_symbol":[]},"alphafold":{"accession":"Q01664","domains":[{"cath_id":"-","chopping":"17-74","consensus_level":"medium","plddt":80.2933,"start":17,"end":74}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q01664","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q01664-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q01664-F1-predicted_aligned_error_v6.png","plddt_mean":72.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TFAP4","jax_strain_url":"https://www.jax.org/strain/search?query=TFAP4"},"sequence":{"accession":"Q01664","fasta_url":"https://rest.uniprot.org/uniprotkb/Q01664.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q01664/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q01664"}},"corpus_meta":[{"pmid":"2833704","id":"PMC_2833704","title":"Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro.","date":"1988","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2833704","citation_count":307,"is_preprint":false},{"pmid":"2123466","id":"PMC_2123466","title":"Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity.","date":"1990","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/2123466","citation_count":304,"is_preprint":false},{"pmid":"10066790","id":"PMC_10066790","title":"AP-4, a novel protein complex related to clathrin adaptors.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10066790","citation_count":234,"is_preprint":false},{"pmid":"20230749","id":"PMC_20230749","title":"Sorting of the Alzheimer's disease amyloid precursor protein mediated by the AP-4 complex.","date":"2010","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/20230749","citation_count":215,"is_preprint":false},{"pmid":"2200736","id":"PMC_2200736","title":"Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs.","date":"1990","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/2200736","citation_count":180,"is_preprint":false},{"pmid":"11802162","id":"PMC_11802162","title":"AP-4 binds basolateral signals and participates in basolateral sorting in epithelial MDCK cells.","date":"2002","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11802162","citation_count":161,"is_preprint":false},{"pmid":"20972249","id":"PMC_20972249","title":"Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability.","date":"2010","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20972249","citation_count":140,"is_preprint":false},{"pmid":"29180427","id":"PMC_29180427","title":"AP-4 mediates export of ATG9A from the trans-Golgi network to promote autophagosome formation.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29180427","citation_count":139,"is_preprint":false},{"pmid":"16540471","id":"PMC_16540471","title":"Transcriptional repression of human immunodeficiency virus type 1 by AP-4.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16540471","citation_count":130,"is_preprint":false},{"pmid":"30262884","id":"PMC_30262884","title":"AP-4 vesicles contribute to spatial control of autophagy via RUSC-dependent peripheral delivery of ATG9A.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30262884","citation_count":127,"is_preprint":false},{"pmid":"18341993","id":"PMC_18341993","title":"Accumulation of AMPA receptors in autophagosomes in neuronal axons lacking adaptor protein AP-4.","date":"2008","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/18341993","citation_count":125,"is_preprint":false},{"pmid":"23167973","id":"PMC_23167973","title":"Adaptor protein complexes AP-4 and AP-5: new players in endosomal trafficking and progressive spastic paraplegia.","date":"2012","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/23167973","citation_count":116,"is_preprint":false},{"pmid":"11139587","id":"PMC_11139587","title":"Signal-binding specificity of the mu4 subunit of the adaptor protein complex AP-4.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11139587","citation_count":112,"is_preprint":false},{"pmid":"29698489","id":"PMC_29698489","title":"Altered distribution of ATG9A and accumulation of axonal aggregates in neurons from a mouse model of AP-4 deficiency syndrome.","date":"2018","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29698489","citation_count":95,"is_preprint":false},{"pmid":"11707398","id":"PMC_11707398","title":"Functional and physical interactions of the adaptor protein complex AP-4 with ADP-ribosylation factors (ARFs).","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11707398","citation_count":95,"is_preprint":false},{"pmid":"30026867","id":"PMC_30026867","title":"Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinoma.","date":"2018","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/30026867","citation_count":85,"is_preprint":false},{"pmid":"26546666","id":"PMC_26546666","title":"The Adaptor Complex AP-4 Regulates Vacuolar Protein Sorting at the trans-Golgi Network by Interacting with VACUOLAR SORTING RECEPTOR1.","date":"2015","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26546666","citation_count":72,"is_preprint":false},{"pmid":"31142229","id":"PMC_31142229","title":"Axonal autophagosome maturation defect through failure of ATG9A sorting underpins pathology in AP-4 deficiency syndrome.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31142229","citation_count":69,"is_preprint":false},{"pmid":"14572453","id":"PMC_14572453","title":"Adaptor protein complex-4 (AP-4) is expressed in the central nervous system neurons and interacts with glutamate receptor delta2.","date":"2003","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/14572453","citation_count":53,"is_preprint":false},{"pmid":"25552650","id":"PMC_25552650","title":"Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25552650","citation_count":49,"is_preprint":false},{"pmid":"24781758","id":"PMC_24781758","title":"An AP4B1 frameshift mutation in siblings with intellectual disability and spastic tetraplegia further delineates the AP-4 deficiency syndrome.","date":"2014","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/24781758","citation_count":44,"is_preprint":false},{"pmid":"35217685","id":"PMC_35217685","title":"AP-4-mediated axonal transport controls endocannabinoid production in neurons.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35217685","citation_count":41,"is_preprint":false},{"pmid":"31281549","id":"PMC_31281549","title":"TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway.","date":"2019","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/31281549","citation_count":34,"is_preprint":false},{"pmid":"25038464","id":"PMC_25038464","title":"Wnt/β-catenin signaling regulates Helicoverpa armigera pupal development by up-regulating c-Myc and AP-4.","date":"2014","source":"Insect biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25038464","citation_count":33,"is_preprint":false},{"pmid":"31552102","id":"PMC_31552102","title":"MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4.","date":"2019","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31552102","citation_count":33,"is_preprint":false},{"pmid":"33282915","id":"PMC_33282915","title":"Re-evaluation of Diadenosine Tetraphosphate (Ap4A) From a Stress Metabolite to Bona Fide Secondary Messenger.","date":"2020","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/33282915","citation_count":32,"is_preprint":false},{"pmid":"33205649","id":"PMC_33205649","title":"Cucurbitacin E Chemosensitizes Colorectal Cancer Cells via Mitigating TFAP4/Wnt/β-Catenin Signaling.","date":"2020","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33205649","citation_count":31,"is_preprint":false},{"pmid":"11839306","id":"PMC_11839306","title":"The structure of Ap(4)A hydrolase complexed with ATP-MgF(x) reveals the basis of substrate binding.","date":"2002","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/11839306","citation_count":30,"is_preprint":false},{"pmid":"22615908","id":"PMC_22615908","title":"Down-regulation of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human gastric cancer cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22615908","citation_count":30,"is_preprint":false},{"pmid":"21719561","id":"PMC_21719561","title":"Breast cancer cells proliferation is regulated by tyrosine phosphatase SHP1 through c-jun N-terminal kinase and cooperative induction of RFX-1 and AP-4 transcription factors.","date":"2011","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/21719561","citation_count":29,"is_preprint":false},{"pmid":"15377281","id":"PMC_15377281","title":"The adaptor protein AP-4 as a component of the clathrin coat machinery: a morphological study.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15377281","citation_count":27,"is_preprint":false},{"pmid":"29906744","id":"PMC_29906744","title":"MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/29906744","citation_count":27,"is_preprint":false},{"pmid":"32073997","id":"PMC_32073997","title":"The FTS-Hook-FHIP (FHF) complex interacts with AP-4 to mediate perinuclear distribution of AP-4 and its cargo ATG9A.","date":"2020","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/32073997","citation_count":27,"is_preprint":false},{"pmid":"25496299","id":"PMC_25496299","title":"A novel AP4M1 mutation in autosomal recessive cerebral palsy syndrome and clinical expansion of AP-4 deficiency.","date":"2014","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25496299","citation_count":27,"is_preprint":false},{"pmid":"21137581","id":"PMC_21137581","title":"Specific phosphorylase from Euglena gracilis splits diadenosine 5',5'''-P(1),P(4)-tetraphosphate (Ap(4)A) and diadenosine 5',5'''-P(1),P(3)-triphosphate (Ap(3)A).","date":"1988","source":"The International journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21137581","citation_count":25,"is_preprint":false},{"pmid":"24500709","id":"PMC_24500709","title":"Proteasome-dependent degradation of transcription factor activating enhancer-binding protein 4 (TFAP4) controls mitotic division.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24500709","citation_count":24,"is_preprint":false},{"pmid":"11171123","id":"PMC_11171123","title":"Transcription factor AP-4 is a ligand for immunoglobulin-kappa promoter E-box elements.","date":"2001","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11171123","citation_count":24,"is_preprint":false},{"pmid":"7800474","id":"PMC_7800474","title":"Transcription factor AP-4 participates in activation of bovine leukemia virus long terminal repeat by p34 Tax.","date":"1994","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/7800474","citation_count":24,"is_preprint":false},{"pmid":"26542808","id":"PMC_26542808","title":"Bivalent Motif-Ear Interactions Mediate the Association of the Accessory Protein Tepsin with the AP-4 Adaptor Complex.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26542808","citation_count":22,"is_preprint":false},{"pmid":"33373169","id":"PMC_33373169","title":"An integrated pan-cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33373169","citation_count":21,"is_preprint":false},{"pmid":"19505873","id":"PMC_19505873","title":"Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.","date":"2009","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/19505873","citation_count":21,"is_preprint":false},{"pmid":"35976706","id":"PMC_35976706","title":"AP-4 regulates neuronal lysosome composition, function, and transport via regulating export of critical lysosome receptor proteins at the trans-Golgi network.","date":"2022","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/35976706","citation_count":21,"is_preprint":false},{"pmid":"31604935","id":"PMC_31604935","title":"Second messenger Ap4A polymerizes target protein HINT1 to transduce signals in FcεRI-activated mast cells.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31604935","citation_count":20,"is_preprint":false},{"pmid":"9741833","id":"PMC_9741833","title":"A distal regulatory region of the insulin-like growth factor binding protein-2 (IGFBP-2) gene interacts with the basic helix-loop-helix transcription factor, AP-4.","date":"1998","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/9741833","citation_count":20,"is_preprint":false},{"pmid":"35192356","id":"PMC_35192356","title":"Cucurbitacin E Triggers Cellular Senescence in Colon Cancer Cells via Regulating the miR-371b-5p/TFAP4 Signaling Pathway.","date":"2022","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35192356","citation_count":19,"is_preprint":false},{"pmid":"29845218","id":"PMC_29845218","title":"Elevated TFAP4 regulates lncRNA TRERNA1 to promote cell migration and invasion in gastric cancer.","date":"2018","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/29845218","citation_count":18,"is_preprint":false},{"pmid":"36074102","id":"PMC_36074102","title":"TFAP4 Activates IGF2BP1 and Promotes Progression of Non-Small Cell Lung Cancer by Stabilizing TK1 Expression through m6A Modification.","date":"2022","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/36074102","citation_count":18,"is_preprint":false},{"pmid":"38233389","id":"PMC_38233389","title":"High-content screening identifies a small molecule that restores AP-4-dependent protein trafficking in neuronal models of AP-4-associated hereditary spastic paraplegia.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38233389","citation_count":18,"is_preprint":false},{"pmid":"31943575","id":"PMC_31943575","title":"Transcription factor AP-4 (TFAP4)-upstream ORF coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the TFAP4/long noncoding RNA 00520/microRNA-520f-3p feedback loop.","date":"2020","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/31943575","citation_count":18,"is_preprint":false},{"pmid":"21402779","id":"PMC_21402779","title":"Importin beta plays an essential role in the regulation of the LysRS-Ap(4)A pathway in immunologically activated mast cells.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21402779","citation_count":17,"is_preprint":false},{"pmid":"33084855","id":"PMC_33084855","title":"The role of AP-4 in cargo export from the trans-Golgi network and hereditary spastic paraplegia.","date":"2020","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/33084855","citation_count":16,"is_preprint":false},{"pmid":"24420882","id":"PMC_24420882","title":"Production of a thermophilic, extracellular alkaline protease by Bacillus stearothermophilus AP-4.","date":"1994","source":"World journal of microbiology & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/24420882","citation_count":16,"is_preprint":false},{"pmid":"19481121","id":"PMC_19481121","title":"Polarized sorting of AMPA receptors to the somatodendritic domain is regulated by adaptor protein AP-4.","date":"2009","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/19481121","citation_count":15,"is_preprint":false},{"pmid":"37934413","id":"PMC_37934413","title":"Diadenosine Tetraphosphate (Ap4 A) Serves as a 5' RNA Cap in Mammalian Cells.","date":"2023","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/37934413","citation_count":14,"is_preprint":false},{"pmid":"21810154","id":"PMC_21810154","title":"The epsilon hinge-ear region regulates membrane localization of the AP-4 complex.","date":"2011","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/21810154","citation_count":14,"is_preprint":false},{"pmid":"25888431","id":"PMC_25888431","title":"Cropped, Drosophila transcription factor AP-4, controls tracheal terminal branching and cell growth.","date":"2015","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/25888431","citation_count":13,"is_preprint":false},{"pmid":"21988553","id":"PMC_21988553","title":"Phospholipase C/Protein Kinase C pathway is essential for corneal re-epithelialization induced by Ap(4)A.","date":"2011","source":"Current eye research","url":"https://pubmed.ncbi.nlm.nih.gov/21988553","citation_count":13,"is_preprint":false},{"pmid":"29430868","id":"PMC_29430868","title":"A novel homozygous AP4B1 mutation in two brothers with AP-4 deficiency syndrome and ocular anomalies.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/29430868","citation_count":13,"is_preprint":false},{"pmid":"35976721","id":"PMC_35976721","title":"The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits.","date":"2022","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/35976721","citation_count":11,"is_preprint":false},{"pmid":"27761681","id":"PMC_27761681","title":"Diadenosine tetraphosphate (Ap4A) inhibits ATP-induced excitotoxicity: a neuroprotective strategy for traumatic spinal cord injury treatment.","date":"2016","source":"Purinergic signalling","url":"https://pubmed.ncbi.nlm.nih.gov/27761681","citation_count":11,"is_preprint":false},{"pmid":"31530880","id":"PMC_31530880","title":"The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31530880","citation_count":10,"is_preprint":false},{"pmid":"34283887","id":"PMC_34283887","title":"Unexpected suppression of tumorigenesis by c-MYC via TFAP4-dependent restriction of stemness in B lymphocytes.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/34283887","citation_count":10,"is_preprint":false},{"pmid":"34630654","id":"PMC_34630654","title":"TFAP4 promotes the growth of prostate cancer cells by upregulating FOXK1.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34630654","citation_count":10,"is_preprint":false},{"pmid":"33717268","id":"PMC_33717268","title":"MicroRNA-124 suppresses the invasion and proliferation of breast cancer cells by targeting TFAP4.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33717268","citation_count":9,"is_preprint":false},{"pmid":"18654090","id":"PMC_18654090","title":"AP-4: autophagy-four mislocalized proteins in axons.","date":"2008","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/18654090","citation_count":9,"is_preprint":false},{"pmid":"10620341","id":"PMC_10620341","title":"Selective degradation of 2'-adenylated diadenosine tri- and tetraphosphates, Ap(3)A and Ap(4)A, by two specific human dinucleoside polyphosphate hydrolases.","date":"2000","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/10620341","citation_count":9,"is_preprint":false},{"pmid":"34141611","id":"PMC_34141611","title":"Silencing of the Long Non-Coding RNA TTN-AS1 Attenuates the Malignant Progression of Osteosarcoma Cells by Regulating the miR-16-1-3p/TFAP4 Axis.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34141611","citation_count":8,"is_preprint":false},{"pmid":"38281682","id":"PMC_38281682","title":"The Reelin receptor ApoER2 is a cargo for the adaptor protein complex AP-4: Implications for Hereditary Spastic Paraplegia.","date":"2024","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/38281682","citation_count":8,"is_preprint":false},{"pmid":"38847328","id":"PMC_38847328","title":"USP15, activated by TFAP4 transcriptionally, stabilizes SHC1 via deubiquitination and deteriorates renal cell carcinoma.","date":"2024","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/38847328","citation_count":7,"is_preprint":false},{"pmid":"38801926","id":"PMC_38801926","title":"Ubiquitin-specific peptidase 15 regulates the TFAP4/PCGF1 axis facilitating liver metastasis of colorectal cancer and cell stemness.","date":"2024","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38801926","citation_count":7,"is_preprint":false},{"pmid":"35001801","id":"PMC_35001801","title":"Inhibitory effect of CC chemokine ligand 23 (CCL23)/ transcription factor activating enhancer binding protein 4 (TFAP4) on cell proliferation, invasion and angiogenesis in hepatocellular carcinoma.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35001801","citation_count":7,"is_preprint":false},{"pmid":"37610449","id":"PMC_37610449","title":"Downregulation of miR-144 blocked the proliferation and invasion of nerve cells in Hirschsprung disease by regulating Transcription Factor AP 4 (TFAP4).","date":"2023","source":"Pediatric surgery international","url":"https://pubmed.ncbi.nlm.nih.gov/37610449","citation_count":7,"is_preprint":false},{"pmid":"31254530","id":"PMC_31254530","title":"Ap4A Regulates Directional Mobility and Antigen Presentation in Dendritic Cells.","date":"2019","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/31254530","citation_count":6,"is_preprint":false},{"pmid":"36894688","id":"PMC_36894688","title":"Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis.","date":"2023","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/36894688","citation_count":5,"is_preprint":false},{"pmid":"37060810","id":"PMC_37060810","title":"TFAP4 promotes the progression of liver fibrosis through regulating double-negative T cell differentiation via OX40.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37060810","citation_count":5,"is_preprint":false},{"pmid":"39827671","id":"PMC_39827671","title":"TFAP4 regulates the progression of liver fibrosis through the STING signaling pathway.","date":"2025","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39827671","citation_count":5,"is_preprint":false},{"pmid":"37170211","id":"PMC_37170211","title":"BPTF in bone marrow provides a potential progression biomarker regulated by TFAP4 through the PI3K/AKT pathway in neuroblastoma.","date":"2023","source":"Biological procedures online","url":"https://pubmed.ncbi.nlm.nih.gov/37170211","citation_count":4,"is_preprint":false},{"pmid":"38475725","id":"PMC_38475725","title":"Chromatin profiling reveals TFAP4 as a critical transcriptional regulator of bovine satellite cell differentiation.","date":"2024","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/38475725","citation_count":4,"is_preprint":false},{"pmid":"39215599","id":"PMC_39215599","title":"Rapid Vacuolar Sorting of the Borate Transporter BOR1 Requires the Adaptor Protein Complex AP-4 in Arabidopsis.","date":"2024","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/39215599","citation_count":4,"is_preprint":false},{"pmid":"11735304","id":"PMC_11735304","title":"Characterization of microsatellite markers adjacent to AP-4 on chromosome 16p13.3.","date":"2001","source":"Molecular and cellular probes","url":"https://pubmed.ncbi.nlm.nih.gov/11735304","citation_count":4,"is_preprint":false},{"pmid":"36642642","id":"PMC_36642642","title":"AP-4 loss in CRISPR-edited zebrafish affects early embryo development.","date":"2022","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/36642642","citation_count":4,"is_preprint":false},{"pmid":"27313685","id":"PMC_27313685","title":"Silencing of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human lung cancer cells.","date":"2016","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/27313685","citation_count":4,"is_preprint":false},{"pmid":"28414592","id":"PMC_28414592","title":"Understanding the Presence and Roles of Ap4A (Diadenosine Tetraphosphate) in the Eye.","date":"2017","source":"Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/28414592","citation_count":3,"is_preprint":false},{"pmid":"34070694","id":"PMC_34070694","title":"The pLysRS-Ap4A Pathway in Mast Cells Regulates the Switch from Host Defense to a Pathological State.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34070694","citation_count":3,"is_preprint":false},{"pmid":"38334330","id":"PMC_38334330","title":"Lymphocytic choriomeningitis arenavirus requires cellular COPI and AP-4 complexes for efficient virion production.","date":"2024","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/38334330","citation_count":3,"is_preprint":false},{"pmid":"32895917","id":"PMC_32895917","title":"Comprehensive genotype-phenotype correlation in AP-4 deficiency syndrome; Adding data from a large cohort of Iranian patients.","date":"2020","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32895917","citation_count":3,"is_preprint":false},{"pmid":"40612272","id":"PMC_40612272","title":"TFAP4 exacerbates pathological cardiac fibrosis by modulating mechanotransduction.","date":"2025","source":"Cell insight","url":"https://pubmed.ncbi.nlm.nih.gov/40612272","citation_count":3,"is_preprint":false},{"pmid":"7557429","id":"PMC_7557429","title":"AP-4- and AP-5-like proteins from mouse L cells are trans-activators and bind to the GT-II region of SV40 early TRE in a mutually exclusive manner.","date":"1995","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/7557429","citation_count":3,"is_preprint":false},{"pmid":"29948577","id":"PMC_29948577","title":"Increased Ap4A levels and ecto-nucleotidase activity in glaucomatous mice retina.","date":"2018","source":"Purinergic signalling","url":"https://pubmed.ncbi.nlm.nih.gov/29948577","citation_count":2,"is_preprint":false},{"pmid":"39400106","id":"PMC_39400106","title":"circ_0006988 promotes gastric cancer cell proliferation, migration and invasion through miRNA-92a-2-5p/TFAP4 axis.","date":"2024","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/39400106","citation_count":1,"is_preprint":false},{"pmid":"40106574","id":"PMC_40106574","title":"Genome-wide CRISPR screen identifies IRF1 and TFAP4 as transcriptional regulators of Galectin-9 in T cell acute lymphoblastic leukemia.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40106574","citation_count":1,"is_preprint":false},{"pmid":"39971831","id":"PMC_39971831","title":"TFAP4 Regulation of MCM5 Activates the PI3K/AKT Pathway to Promote Invasion and Metastasis of Gastric Cancer.","date":"2025","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39971831","citation_count":1,"is_preprint":false},{"pmid":"41198464","id":"PMC_41198464","title":"The AP-4 accessory protein tepsin exhibits multivalent binding to LC3B.","date":"2025","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/41198464","citation_count":1,"is_preprint":false},{"pmid":"33859675","id":"PMC_33859675","title":"Corrigendum: MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33859675","citation_count":1,"is_preprint":false},{"pmid":"39632089","id":"PMC_39632089","title":"Axonal organelle buildup from loss of AP-4 complex function causes exacerbation of amyloid plaque pathology and gliosis in Alzheimer's disease mouse model.","date":"2024","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/39632089","citation_count":1,"is_preprint":false},{"pmid":"38069010","id":"PMC_38069010","title":"The Plasma Membrane Purinoreceptor P2K1/DORN1 Is Essential in Stomatal Closure Evoked by Extracellular Diadenosine Tetraphosphate (Ap4A) in Arabidopsis thaliana.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38069010","citation_count":1,"is_preprint":false},{"pmid":"38187774","id":"PMC_38187774","title":"The Reelin Receptor ApoER2 is a Cargo for the Adaptor Protein Complex AP-4: Implications for Hereditary Spastic Paraplegia.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38187774","citation_count":1,"is_preprint":false},{"pmid":"37398196","id":"PMC_37398196","title":"High-Content Small Molecule Screen Identifies a Novel Compound That Restores AP-4-Dependent Protein Trafficking in Neuronal Models of AP-4-Associated Hereditary Spastic Paraplegia.","date":"2023","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/37398196","citation_count":1,"is_preprint":false},{"pmid":"41565640","id":"PMC_41565640","title":"Structural basis for the dynamic conformations of AP-4 and its association with ARF1.","date":"2026","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41565640","citation_count":0,"is_preprint":false},{"pmid":"40962169","id":"PMC_40962169","title":"TFAP4/DLGAP5 promotes tumor progression and macrophage M2 polarization in prostate cancer by activating the JAK2/STAT3 signaling.","date":"2025","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/40962169","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49128,"output_tokens":5389,"usd":0.11411},"stage2":{"model":"claude-opus-4-6","input_tokens":9006,"output_tokens":3326,"usd":0.19227},"total_usd":0.30638,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"AP-4 (TFAP4) was isolated as an enhancer-binding factor that recognizes a motif in the SV40 A-domain and activates SV40 late transcription in vitro; this stimulation is augmented by AP-1 binding to adjacent sequences, demonstrating coordinate action of the two factors for transcriptional enhancement.\",\n      \"method\": \"In vitro transcription assay with purified AP-4 protein\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified factor, foundational discovery paper\",\n      \"pmids\": [\"2833704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Human AP-4 (TFAP4) is a helix-loop-helix (HLH) protein that binds the symmetrical DNA sequence CAGCTG; it contains an HLH motif plus two additional leucine repeat elements (LR1 and LR2) that promote homodimerization and restrict heterodimer formation with other HLH proteins such as E12. The LR1/LR2 domains are required for solution-phase dimerization, while the HLH-basic region is sufficient for DNA binding.\",\n      \"method\": \"Molecular cloning, deletion/point mutagenesis, DNA-binding and dimerization assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with multiple biochemical assays, original cloning paper\",\n      \"pmids\": [\"2123466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TFAP4 represses HIV-1 LTR transcription by recruiting histone deacetylase 1 (HDAC1) to the LTR promoter and by masking TATA-binding protein (TBP) binding to the TATA box; TFAP4 and HDAC1 are present on the LTR in latently infected cells and dissociate upon TNF-α-induced reactivation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay, chromatin immunoprecipitation (ChIP), siRNA knockdown, luciferase reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including ChIP, co-IP, in vitro binding, and functional knockdown in a single study\",\n      \"pmids\": [\"16540471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TFAP4 binds an E-box in the HDM2-P2 promoter via its C-terminal Gln/Pro-rich domain and represses HDM2 transcription in a p53-independent manner; AP-4 forms a complex containing HDAC1, CTCF, SP1, histone methyltransferases, and SWI/SNF components at the HDM2-P2 promoter.\",\n      \"method\": \"Luciferase reporter assay, AP-4 truncation mutants, DNA-affinity purification followed by quantitative proteomics (cICAT and iTRAQ), co-immunoprecipitation\",\n      \"journal\": \"Molecular & cellular proteomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding, mutagenesis, and quantitative MS-based interactomics with orthogonal validation\",\n      \"pmids\": [\"19505873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"During G2 phase of the cell cycle, TFAP4 is targeted for proteasome-dependent degradation by the SCF-βTrCP ubiquitin ligase, requiring phosphorylation of TFAP4 on a conserved degron; expression of a stable TFAP4 mutant unable to interact with βTrCP causes chromosome missegregation, multipolar spindles, and DNA damage response activation.\",\n      \"method\": \"Biochemical degradation assays, site-directed mutagenesis of degron, cell cycle analysis, immunofluorescence for mitotic defects, mass spectrometry\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — phosphorylation-dependent ubiquitin ligase interaction with mutagenesis and clear cellular phenotype\",\n      \"pmids\": [\"24500709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TFAP4 activates Wnt/β-catenin signaling in hepatocellular carcinoma by directly binding to the promoters of DVL1 and LEF1, as demonstrated by luciferase reporter and ChIP-qPCR assays.\",\n      \"method\": \"Luciferase reporter assay, ChIP-qPCR, overexpression/knockdown functional assays\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding demonstrated by ChIP and luciferase reporter in a single lab study\",\n      \"pmids\": [\"30026867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TFAP4 acts as a transcriptional ligand for immunoglobulin-κ promoter E-box elements (5′-CAGCTG-3′) and does not act as a transactivator at these sites, distinguishing it from E47.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA) with nuclear extracts from human and murine B-cell lines\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EMSA with specific nuclear extracts, single lab\",\n      \"pmids\": [\"11171123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"AP-4 participates in BLV Tax trans-activation by binding a CAGCTG AP-4 site in the 21-bp repeats of the BLV LTR; antisense AP-4 RNA strongly reduces Tax activation, indicating AP-4 is required for this viral trans-activation.\",\n      \"method\": \"Gel retardation assay, in vivo reporter assay, antisense RNA knockdown\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional antisense knockdown combined with binding assay, single lab\",\n      \"pmids\": [\"7800474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"AP-4 binds E-box (CACCTG) motifs in a distal regulatory region of the IGFBP-2 gene and activates IGFBP-2 promoter activity 16-fold when co-transfected with an AP-4 expression vector; stimulation is abolished by mutation of both bHLH motifs.\",\n      \"method\": \"EMSA, Southwestern blot, co-transfection luciferase reporter assay with AP-4 expression vector\",\n      \"journal\": \"Endocrine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct DNA binding and functional reporter assay with mutagenesis, single lab\",\n      \"pmids\": [\"9741833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In IGF-1-stimulated breast cancer cells, JNK activation induces SHP1 expression through binding of TFAP4 and RFX-1 transcription factors to the epithelial tissue-specific SHP1 promoter.\",\n      \"method\": \"Promoter reporter assay, transcription factor binding assay, JNK inhibition experiments\",\n      \"journal\": \"Molecular cancer research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, limited mechanistic detail on TFAP4-specific binding at promoter\",\n      \"pmids\": [\"21719561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"c-MYC suppresses the stemness of developing B cells and counteracts oncogenesis by inducing TFAP4, which restricts self-renewal of proliferating B cells; CRISPR deletion of TFAP4 in Eµ-MYC hematopoietic stem and progenitor cells accelerates c-MYC-driven lymphoma development and reduces expression of B cell differentiation regulators Spi1, SpiB, and Pax5 that are direct target genes of TFAP4.\",\n      \"method\": \"CRISPR knockout in primary hematopoietic cells with in vivo transplantation, transcriptional profiling, genetic epistasis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo epistasis with CRISPR, transcriptome analysis, and clear functional phenotype\",\n      \"pmids\": [\"34283887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In Drosophila, Cropped (the AP-4 ortholog) is required for tracheal terminal cell branching and is controlled by dMyc; ectopic dMyc increases Cropped protein levels and cellular branching, placing AP-4 downstream of Myc in a branching morphogenesis pathway.\",\n      \"method\": \"Genetic overexpression and loss-of-function in Drosophila tracheal cells, cell counting, protein level analysis\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic epistasis in Drosophila ortholog, single lab\",\n      \"pmids\": [\"25888431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TFAP4 directly binds to the promoter of OX40 (acting as its transcription factor) and promotes OX40 expression, thereby accelerating double-negative T cell (DNT) differentiation; myeloid-specific TFAP4 knockout reduced DNTs in liver tissue and delayed liver fibrosis progression.\",\n      \"method\": \"Luciferase reporter assay, ChIP, overexpression and myeloid-specific knockout mouse model\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding by ChIP/luciferase combined with in vivo KO phenotype, single lab\",\n      \"pmids\": [\"37060810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TFAP4 transcriptionally activates IGF2BP1 by binding its promoter; IGF2BP1 then stabilizes TK1 mRNA via m6A modification to promote NSCLC cell proliferation, migration, and invasion.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, m6A modification detection, knockdown/overexpression, in vivo xenograft\",\n      \"journal\": \"Molecular cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding by ChIP/luciferase with downstream mechanistic follow-up, single lab\",\n      \"pmids\": [\"36074102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TFAP4 transcriptionally activates the USP15 promoter (confirmed by ChIP and pull-down assay); USP15 in turn deubiquitinates and stabilizes SHC1 protein, promoting renal cell carcinoma malignancy.\",\n      \"method\": \"ChIP assay, oligonucleotide pull-down assay, co-immunoprecipitation, ubiquitination assay, in vivo xenograft\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal assays establishing TFAP4→USP15 transcriptional axis, single lab\",\n      \"pmids\": [\"38847328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP15 deubiquitinates TFAP4 and enhances its protein stability; stabilized TFAP4 transcriptionally activates PCGF1 to promote colorectal cancer metastasis and stemness.\",\n      \"method\": \"Co-immunoprecipitation, dual luciferase reporter assay, oligonucleotide pull-down, ChIP assay, in vivo liver metastasis model\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods establishing deubiquitination and transcriptional activation, single lab\",\n      \"pmids\": [\"38801926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TFAP4 binds the rs1800734 region of the MLH1 promoter (confirmed by allele-specific binding assay), but binding is much weaker to the cancer risk allele than the protective allele; TFAP4 binding is absent when promoter methylation is present, suggesting TFAP4 shields the protective allele from BRAF-induced methylation.\",\n      \"method\": \"Allele-specific TFAP4 binding assay, methylation analysis, re-expression after methylation inhibitor treatment\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding assay with allele-specific discrimination and functional follow-up, single lab\",\n      \"pmids\": [\"31530880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TFAP4 directly activates expression of mechanosensors Itga11 and Piezo2 (confirmed by ChIP/luciferase), promoting cardiac fibroblast activation, ECM deposition, and myofibroblast differentiation; silencing Itga11 and Piezo2 reverses TFAP4's pro-fibrotic effects.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, overexpression/knockdown, in vivo mouse post-MI model\",\n      \"journal\": \"Cell insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding by ChIP/luciferase with in vivo validation, single lab\",\n      \"pmids\": [\"40612272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TFAP4 transcriptionally activates the DLGAP5 promoter (confirmed by ChIP and luciferase assay); the TFAP4/DLGAP5 axis activates JAK2/STAT3 signaling in prostate cancer cells to promote tumor progression and macrophage M2 polarization.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, knockdown/overexpression, co-culture macrophage polarization assay, in vivo xenograft\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding by ChIP/luciferase with pathway inhibitor validation, single lab\",\n      \"pmids\": [\"40962169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TFAP4 binds the STING promoter and transcriptionally activates STING expression (shown by luciferase reporter gene experiment), thereby promoting STING signaling pathway activation and progression of liver fibrosis.\",\n      \"method\": \"Luciferase reporter assay, AAV8-TFAP4 overexpression in mice, STING-KO mouse epistasis\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — luciferase reporter with in vivo epistasis (STING-KO), single lab\",\n      \"pmids\": [\"39827671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TFAP4 directly binds E-box motifs in the TRERNA1 promoter and transcriptionally regulates TRERNA1 long non-coding RNA expression in gastric cancer cells (confirmed by dual luciferase reporter and ChIP assay); TRERNA1 promotes gastric cancer cell migration and invasion.\",\n      \"method\": \"Dual luciferase reporter assay, ChIP, knockdown/overexpression\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter binding by ChIP and luciferase reporter, single lab\",\n      \"pmids\": [\"29845218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TFAP4 transcriptionally activates FOXK1 expression in prostate cancer; FOXK1 overexpression reverses the effects of TFAP4 knockdown on cell viability, migration, and invasion.\",\n      \"method\": \"RT-qPCR, Western blot, rescue overexpression experiment, CCK-8, Transwell assays\",\n      \"journal\": \"Experimental and therapeutic medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — genetic rescue experiment without direct promoter binding assay\",\n      \"pmids\": [\"34630654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In T-ALL, TFAP4 binds an enhancer element to fine-tune Galectin-9 expression (identified by genome-wide CRISPR screen and transcription factor binding assay), while IRF1 binds the promoter as the primary driver.\",\n      \"method\": \"Genome-wide CRISPR screen, transcription factor binding assay, enhancer mapping, chromatin accessibility analysis\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide unbiased CRISPR screen validated by direct binding assay, single lab\",\n      \"pmids\": [\"40106574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TFAP4 transcriptionally activates BPTF expression and promotes EMT through activating the PI3K/AKT signaling pathway in neuroblastoma, with BPTF acting as the downstream effector.\",\n      \"method\": \"Western blot, knockdown/overexpression, functional assays; upstream regulatory relationship inferred from protein co-expression and inhibitor studies\",\n      \"journal\": \"Biological procedures online\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — no direct promoter binding assay for TFAP4→BPTF; mechanism largely inferred\",\n      \"pmids\": [\"37170211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TFAP4 is required for differentiation and fusion of bovine satellite cells into myofibers; active enhancers in differentiating satellite cells are enriched for TFAP4 binding sites, and TFAP4 knockdown or overexpression experimentally alters differentiation.\",\n      \"method\": \"ChIP-seq for histone modifications, TFAP4 knockdown and overexpression in bovine satellite cells\",\n      \"journal\": \"BMC genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq-based chromatin profiling combined with functional KD/OE with defined differentiation phenotype\",\n      \"pmids\": [\"38475725\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TFAP4 is a basic helix-loop-helix transcription factor that homodimerizes via leucine repeat elements and binds CAGCTG E-box motifs to activate or repress target gene transcription; it is degraded during G2 phase by SCF-βTrCP-mediated, phosphorylation-dependent ubiquitination to ensure mitotic fidelity, recruits HDAC1 to repress HIV-1 LTR transcription by masking TBP, and directly activates or represses a broad network of target gene promoters (including DVL1, LEF1, OX40, STING, Itga11, Piezo2, IGF2BP1, TRERNA1, and DLGAP5) involved in Wnt/β-catenin signaling, autophagy, immune regulation, and cancer progression.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TFAP4 is a basic helix-loop-helix (bHLH) transcription factor that homodimerizes through leucine repeat elements and binds CAGCTG E-box motifs to activate or repress a broad repertoire of target gene promoters and enhancers, thereby regulating cell proliferation, differentiation, immune signaling, and fibrosis [PMID:2123466, PMID:2833704]. TFAP4 recruits HDAC1 and additional chromatin-modifying complexes to repress transcription at specific loci, including the HIV-1 LTR and the HDM2-P2 promoter, while functioning as a transcriptional activator at numerous other targets including DVL1, LEF1, STING, IGF2BP1, DLGAP5, OX40, Itga11, and Piezo2 [PMID:16540471, PMID:19505873, PMID:30026867, PMID:39827671, PMID:36074102]. During G2 phase, TFAP4 is degraded by SCF-βTrCP-mediated, phosphorylation-dependent ubiquitination; failure to degrade TFAP4 causes chromosome missegregation and multipolar spindles, establishing a cell-cycle-coupled mechanism that ensures mitotic fidelity [PMID:24500709]. As a downstream effector of c-MYC, TFAP4 restricts self-renewal in proliferating B cells by activating differentiation regulators such as Spi1, SpiB, and Pax5, and its loss accelerates MYC-driven lymphomagenesis [PMID:34283887].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"The identity and basic function of AP-4 were unknown; purification and in vitro transcription showed it is an enhancer-binding factor that activates SV40 late transcription, establishing it as a sequence-specific transcriptional activator.\",\n      \"evidence\": \"In vitro transcription assay with purified AP-4 protein on SV40 templates\",\n      \"pmids\": [\"2833704\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No DNA-binding motif defined\", \"No structural information on protein domains\", \"In vivo relevance not tested\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"The structural basis for TFAP4 DNA binding and dimerization was unknown; cloning and mutagenesis revealed a bHLH protein with two additional leucine repeat elements that enforce homodimerization and restrict heterodimer formation, binding the symmetric CAGCTG E-box.\",\n      \"evidence\": \"Molecular cloning, deletion/point mutagenesis, and DNA-binding/dimerization assays\",\n      \"pmids\": [\"2123466\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of HLH+LR domains\", \"Functional consequences of homodimerization specificity unknown\", \"No in vivo target genes identified\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Whether TFAP4 participates in viral gene regulation beyond SV40 was unclear; antisense knockdown showed AP-4 is required for BLV Tax transactivation through binding CAGCTG sites in the BLV LTR, broadening its role to retroviral transcription.\",\n      \"evidence\": \"Gel retardation assay and antisense RNA knockdown with in vivo reporter assay in BLV system\",\n      \"pmids\": [\"7800474\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of Tax–AP-4 cooperation not defined at protein level\", \"No chromatin-level evidence\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The mechanism by which TFAP4 represses transcription was unknown; HDAC1 co-immunoprecipitation and ChIP on the HIV-1 LTR showed TFAP4 recruits HDAC1 and masks TBP binding to enforce latency, establishing a dual repressive mechanism.\",\n      \"evidence\": \"Co-IP, in vitro binding, ChIP, siRNA knockdown, and luciferase reporter in latently HIV-1-infected cells\",\n      \"pmids\": [\"16540471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HDAC1 recruitment is a general TFAP4 repression mechanism or LTR-specific\", \"No structural model of TFAP4–HDAC1 interface\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The composition of TFAP4 repressive complexes was poorly defined; quantitative proteomics at the HDM2-P2 promoter revealed TFAP4 forms a multisubunit complex with HDAC1, CTCF, SP1, histone methyltransferases, and SWI/SNF components, indicating it operates within a broader chromatin-remodeling assemblage.\",\n      \"evidence\": \"DNA-affinity purification with cICAT/iTRAQ quantitative mass spectrometry, co-IP, and truncation mutagenesis\",\n      \"pmids\": [\"19505873\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and stability of the complex not determined\", \"Whether this complex composition is promoter-specific\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"How TFAP4 protein levels are controlled during the cell cycle was unknown; biochemical and mutagenesis experiments showed SCF-βTrCP ubiquitinates TFAP4 in a phosphorylation-dependent manner during G2, and a non-degradable mutant causes mitotic defects, linking TFAP4 turnover to mitotic fidelity.\",\n      \"evidence\": \"Degradation assays, degron mutagenesis, cell cycle synchronization, mass spectrometry for phosphorylation, immunofluorescence for mitotic phenotypes\",\n      \"pmids\": [\"24500709\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for degron phosphorylation not identified\", \"Whether TFAP4 re-accumulation in G1 is transcriptionally or translationally regulated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Whether TFAP4 has pathway-level transcriptional outputs in cancer was unclear; ChIP-qPCR and reporter assays demonstrated direct binding and activation of DVL1 and LEF1 promoters, establishing TFAP4 as an activator of Wnt/β-catenin signaling in hepatocellular carcinoma.\",\n      \"evidence\": \"Luciferase reporter, ChIP-qPCR, overexpression/knockdown in HCC cell lines\",\n      \"pmids\": [\"30026867\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genome-wide set of Wnt pathway targets not defined\", \"Contribution relative to other E-box factors unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The in vivo role of TFAP4 downstream of MYC in normal and malignant hematopoiesis was unresolved; CRISPR deletion in Eμ-MYC HSPCs with transplantation showed TFAP4 restricts B-cell self-renewal and activates differentiation regulators (Spi1, SpiB, Pax5), and its loss accelerates lymphomagenesis.\",\n      \"evidence\": \"CRISPR KO in primary murine hematopoietic cells, in vivo transplantation, transcriptome profiling\",\n      \"pmids\": [\"34283887\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ChIP-seq for TFAP4 at differentiation gene loci not reported\", \"Whether TFAP4 tumor-suppressive function extends beyond MYC-driven B-cell lymphoma\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"The expanding target gene network of TFAP4 in cancer raised questions about downstream effector mechanisms; ChIP and reporter assays showed TFAP4 directly activates IGF2BP1, which stabilizes TK1 mRNA via m6A, connecting TFAP4 to epitranscriptomic regulation of proliferation.\",\n      \"evidence\": \"ChIP, luciferase reporter, m6A detection, knockdown/overexpression, in vivo xenograft in NSCLC\",\n      \"pmids\": [\"36074102\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Genome-wide TFAP4 ChIP-seq in NSCLC not performed\", \"Whether m6A-dependent mRNA stabilization is a general downstream axis\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"TFAP4 protein stability regulation beyond SCF-βTrCP was unknown; co-IP and ubiquitination assays showed USP15 deubiquitinates TFAP4 to enhance its stability, and stabilized TFAP4 activates PCGF1 to promote colorectal cancer metastasis, revealing a reciprocal TFAP4–USP15 regulatory circuit.\",\n      \"evidence\": \"Co-IP, dual luciferase, ChIP, oligonucleotide pull-down, in vivo liver metastasis model (CRC); complementary study showing TFAP4 activates USP15 transcription in RCC\",\n      \"pmids\": [\"38801926\", \"38847328\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the USP15–TFAP4 reciprocal axis operates in normal tissues\", \"Relative contribution of SCF-βTrCP vs USP15 to steady-state TFAP4 levels\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The breadth of TFAP4 transcriptional targets in fibrosis and immune signaling was emerging; multiple studies confirmed direct promoter activation of STING, Itga11, Piezo2, and DLGAP5, linking TFAP4 to innate immune signaling, mechanotransduction in cardiac fibrosis, and JAK2/STAT3 activation.\",\n      \"evidence\": \"ChIP, luciferase reporter, in vivo AAV8 overexpression, STING-KO epistasis, post-MI mouse models, xenograft with macrophage co-culture\",\n      \"pmids\": [\"39827671\", \"40612272\", \"40962169\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No genome-wide ChIP-seq defining complete TFAP4 regulon in any fibrosis model\", \"Selectivity mechanism for activator vs repressor function at different promoters unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the kinase(s) that phosphorylate the TFAP4 degron for SCF-βTrCP recognition, the structural basis for how TFAP4 switches between activator and repressor modes, the comprehensive genome-wide direct target repertoire (no TFAP4 ChIP-seq in human cells has been reported), and the physiological roles of TFAP4 in normal development beyond hematopoiesis and Drosophila tracheal branching.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Degron kinase identity unknown\", \"No crystal or cryo-EM structure of TFAP4 homodimer on DNA\", \"No comprehensive human TFAP4 ChIP-seq dataset\", \"Conditional knockout phenotypes in mammalian tissues beyond hematopoietic and myeloid lineages not reported\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 3, 5, 6, 7, 8, 16, 20, 22, 24]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 3, 5, 10, 12, 13, 14, 17, 18, 19, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [0, 2, 3, 5, 10, 13, 14, 17, 18, 19, 20]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 18, 19]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [12, 22]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [4, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"HDAC1\", \"BTRC\", \"USP15\", \"CTCF\", \"SP1\"],\n    \"other_free_text\": []\n  }\n}\n```"}